Trial intelligence / Profile preview

Testosterone treatment and arterial stiffness in men with type 2 diabetes, peripheral vascular disease and hypogonadism

2005-003652-35Phase 4Completed

Sponsor
Barnsley Hospital NHS Foundation Trust
Start
Nov 2005
Modality
Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Hypoandrogenism (TD), type 2 diabetes mellitus (T2DM) and arteriosclerosis obliterans comparing Sustanon 250 with Placebo (2 arms). Primary endpoint: Change in femoral artery stiffness index beta. Started Nov 2005; status: completed.

02

Drugs

Sustanon 250
03

Conditions

Hypoandrogenism (TD)type 2 diabetes mellitus (T2DM)arteriosclerosis obliterans

Beyond the preview

Go deeper on 2005-003652-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-003652-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call